New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Study: Mitochondria engage the integrated stress response to promote tumor growth

Study: Mitochondria engage the integrated stress response to promote tumor growth

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new editorial paper, titled "Mitochondria engage the integrated stress response to promote tumor growth," was published inOncot
Oncology January 30,2024
Study: Mitochondria engage the integrated stress response to promote tumor growth

Study: Mitochondria engage the integrated stress response to promote tumor growth

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new editorial paper, titled "Mitochondria engage the integrated stress response to promote tumor growth," was published inOncot
Oncology January 30,2024
Billions spent on cancer research but only small percentage goes to treatment, study shows

Billions spent on cancer research but only small percentage goes to treatment, study shows

by University of SouthamptonFunding per year by type of science (A) and proportion of funding per year by type of science (B). Credit:The Lancet Oncology(2023). DOI: 10.1016/S1470-204
Oncology January 30,2024
Billions spent on cancer research but only small percentage goes to treatment, study shows

Billions spent on cancer research but only small percentage goes to treatment, study shows

by University of SouthamptonFunding per year by type of science (A) and proportion of funding per year by type of science (B). Credit:The Lancet Oncology(2023). DOI: 10.1016/S1470-204
Oncology January 30,2024
Researchers identify potential biomarker to distinguish two aggressive types of brain tumors in children

Researchers identify potential biomarker to distinguish two aggressive types of brain tumors in children

by Johns Hopkins University School of MedicineSMYD3 overexpression activates the EGFR pathway in CHLA01 cells. (A) Localization of endogenous SMYD3. Representative 60x Z-stack confocal images sho
Oncology January 30,2024
Researchers identify potential biomarker to distinguish two aggressive types of brain tumors in children

Researchers identify potential biomarker to distinguish two aggressive types of brain tumors in children

by Johns Hopkins University School of MedicineSMYD3 overexpression activates the EGFR pathway in CHLA01 cells. (A) Localization of endogenous SMYD3. Representative 60x Z-stack confocal images sho
Oncology January 30,2024
Long-term collection of patient-reported outcome data in oncology trials: Important and feasible

Long-term collection of patient-reported outcome data in oncology trials: Important and feasible

by Institute for Quality and Efficiency in Health CareCredit: CC0 Public DomainPatient-reported outcome (PRO) data are collected in oncology trials to determine patients' perspectives of canc
Oncology January 30,2024
Long-term collection of patient-reported outcome data in oncology trials: Important and feasible

Long-term collection of patient-reported outcome data in oncology trials: Important and feasible

by Institute for Quality and Efficiency in Health CareCredit: CC0 Public DomainPatient-reported outcome (PRO) data are collected in oncology trials to determine patients' perspectives of canc
Oncology January 30,2024
A new method for conducting a liquid biopsy for liver cancer

A new method for conducting a liquid biopsy for liver cancer

by Bob Yirka , Medical XpressComparison between mutation and methylation fractions in the same cfDNA sample. (A) The correlation between the AF based on mutation and methylation. (B) Comparison of the
Oncology January 30,2024
A new method for conducting a liquid biopsy for liver cancer

A new method for conducting a liquid biopsy for liver cancer

by Bob Yirka , Medical XpressComparison between mutation and methylation fractions in the same cfDNA sample. (A) The correlation between the AF based on mutation and methylation. (B) Comparison of the
Oncology January 30,2024
Research reveals why cancers stop responding to kinase-blocking drugs and come back stronger

Research reveals why cancers stop responding to kinase-blocking drugs and come back stronger

by New York UniversityStructure of the FGFR kinase showing the locations of the gatekeeper residue in blue, hydrophobic spine in yellow, and ATP in cyan. Most drugs bind to the kinase in the same
Oncology January 30,2024
Research reveals why cancers stop responding to kinase-blocking drugs and come back stronger

Research reveals why cancers stop responding to kinase-blocking drugs and come back stronger

by New York UniversityStructure of the FGFR kinase showing the locations of the gatekeeper residue in blue, hydrophobic spine in yellow, and ATP in cyan. Most drugs bind to the kinase in the same
Oncology January 30,2024
Researchers propose biomarkers to select breast cancer patients who could benefit from denosumab treatment

Researchers propose biomarkers to select breast cancer patients who could benefit from denosumab treatment

by The Spanish National Cancer Research CentreGraphical abstract. Credit:EMBO Molecular Medicine(2023). DOI: 10.15252/emmm.202216715The drug denosumab is currently used to treat osteo
Oncology January 30,2024
Researchers propose biomarkers to select breast cancer patients who could benefit from denosumab treatment

Researchers propose biomarkers to select breast cancer patients who could benefit from denosumab treatment

by The Spanish National Cancer Research CentreGraphical abstract. Credit:EMBO Molecular Medicine(2023). DOI: 10.15252/emmm.202216715The drug denosumab is currently used to treat osteo
Oncology January 30,2024
A new nutrition-screening tool for the oncologic population

A new nutrition-screening tool for the oncologic population

byScience China PressVenn plots of three screening tools and malnutrition defined by PG-SGA. Malnutrition was defined as a PG-SGA score of ≥4. The malnutrition risk in MST was defined as an MST
Oncology January 30,2024
A new nutrition-screening tool for the oncologic population

A new nutrition-screening tool for the oncologic population

byScience China PressVenn plots of three screening tools and malnutrition defined by PG-SGA. Malnutrition was defined as a PG-SGA score of ≥4. The malnutrition risk in MST was defined as an MST
Oncology January 30,2024
Quitting smoking early linked with improved survival rates for people diagnosed with lung cancer

Quitting smoking early linked with improved survival rates for people diagnosed with lung cancer

byHarvard T.H. Chan School of Public HealthCredit: Pixabay/CC0 Public DomainQuitting smoking early was associated with higher survival rates following a lung cancer diagnosis, according to a new
Oncology January 30,2024
Quitting smoking early linked with improved survival rates for people diagnosed with lung cancer

Quitting smoking early linked with improved survival rates for people diagnosed with lung cancer

byHarvard T.H. Chan School of Public HealthCredit: Pixabay/CC0 Public DomainQuitting smoking early was associated with higher survival rates following a lung cancer diagnosis, according to a new
Oncology January 30,2024
Novel machine-learning blood test detects cancers with genome-wide mutations in single molecules of cell-free DNA

Novel machine-learning blood test detects cancers with genome-wide mutations in single molecules of cell-free DNA

by Amy Mone,Johns Hopkins UniversitySchematic of overall approach for cancer detection using single-molecule cfDNA sequencing. Credit:Nature Genetics(2023). DOI: 10.1038/s41588-023-0
Oncology January 30,2024
Novel machine-learning blood test detects cancers with genome-wide mutations in single molecules of cell-free DNA

Novel machine-learning blood test detects cancers with genome-wide mutations in single molecules of cell-free DNA

by Amy Mone,Johns Hopkins UniversitySchematic of overall approach for cancer detection using single-molecule cfDNA sequencing. Credit:Nature Genetics(2023). DOI: 10.1038/s41588-023-0
Oncology January 30,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com